Whimbrel MedTech Analyst
Whimbrel MedTech Analyst
Start your first month free

Spend less time researching medtech device companies and more time winning new business.

For medtech business development and sales professionals at firms that sell services to medical device companies. Whimbrel works inside the AI app you already use, like ChatGPT or Claude.

Which US device companies got an FDA IDE approval recently?

Example

The company: Mirrowen Neurovascular (Example), a US stent developer.

Why now: The FDA approved the company's IDE for a pivotal study of its stent.

Made-up example companies; the signal types are real.

What an IDE approval tells you

An IDE (investigational device exemption) lets a company use a device in a clinical study in the US to collect safety and effectiveness data. For a significant risk device, the FDA approves the IDE before the study can start. Companies often announce IDE approvals in press releases, and there is no single public FDA list, so finding them by hand takes a long time. Ask Whimbrel instead, in the AI app you already use, like ChatGPT or Claude.

Source of the signal: company press releases, trade news and ClinicalTrials.gov device trial records. Every fact Whimbrel shows links to its public source and date.

Questions you can ask Whimbrel

Which device companies got an IDE approval this year?
Which device trials are registered but not yet recruiting?
Give me the rundown on a company that just got an IDE.

Pricing

Whimbrel costs $99 a month for one person, or $948 if you pay for a year. Teams of five or more pay $79 a seat a month. Your first month is free. Whimbrel covers US medical device companies only. See pricing for the details, or read how Whimbrel works.

More signal searches

Spend your time selling, not searching.

Add Whimbrel to the AI app you already use and start your first month free.